Technical Analysis – EURCAD sets sight on peak despite recent correction



EURCAD continues to focus on the recent 23-month-peak of 1.5817 even after a pullback below the 1.5449 level, which is the 23.6% Fibonacci retracement of the up leg from the 1.4263 to 1.5817.

The picture appears to suggest that further advances could unfold, aided by the recent bullish crossover in the stochastic lines with room to move, as well as the nearing of a bullish cross between the 200-day simple moving average (SMA) and the 100-day one. Moreover, the upward sloping Tenkan-sen line has distanced itself above its blue Kijun-sen line, while the MACD, well into the positive region, holds above its red trigger line.

However, traders need to be aware of the flattened blue Kijun-sen line (at the 50.0% Fibo) and the RSI that has just slipped below the 70 mark, warning of downside corrections.

Heading north, immediate resistance could come from the 1.5657 hurdle ahead of the multi-month top of 1.5817, which coincides with the inside swing low from back in March of 2018. Conquering the summit, the 1.5925 and 1.6076 obstacles from April and March of 2018 respectively could be next to test the ascent.

Otherwise, if sellers push below the 1.5449 level, support could then rest at the 1.5286 low. Steering down, the 38.2% Fibo of 1.5223 and the 1.5146 support from June 2019 could impede the pair from reaching the 50.0% Fibo of 1.5040 and inside swing highs of 1.4994 and 1.4976.

Overall, a positive near-term picture looks to remain if the pair holds above 1.5286, with a close above 1.5817 cementing further advances.

Latest News

Stocks gain on Powell dovish remarks, outlook remains cloudy – Stock Market News


Week Ahead – Australia and Canada kick off central bank bonanza


Daily Market Comment – NFP awaited as Fed rate hike bets cool, dollar plunges


Technical Analysis – USDCAD steps on 20-SMA; bears still present


Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.